Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 380, pseudogene (RN7SL380P)

Target
RN7SL380P
Molecular classification
Other, Pseudogene, Non-coding RNA
01

Overview

RN7SL380P (RNA, 7SL, cytoplasmic 380, pseudogene) is classified as a pseudogene that is homologous to the 7SL RNA gene, with no evidence of encoding a functional product or exerting direct biological activity[1][5][8]. The human genome contains hundreds of 7SL pseudogenes, which are believed to originate through reverse transcription of mature 7SL RNA and reintegration into the genome[5][8]. These sequences are typically truncated and do not produce a functional 7SL RNA, which normally serves as the essential RNA component of the signal recognition particle complex required for cotranslational targeting of proteins to the endoplasmic reticulum[7]. The pseudogene class (including RN7SL380P) generally does not encode proteins and is not considered a therapeutic target or associated with specific diseases[6]. There is no evidence to suggest that RN7SL380P has any established biomarker, drug interactions, or clinical utility. Note: - This entry is primarily a processed pseudogene, not a protein-coding gene or known regulatory RNA. - There is no described receptor, enzyme, transporter, or signaling function. - "is_incorrect" is set to true because pseudogenes like RN7SL380P are generally not considered valid therapeutic targets or functional molecules in the sense typically meant in drug discovery[1][6][8]. - The small body of research suggests some pseudogenes can have regulatory non-coding RNA functions in specific contexts, but there is no indication that RN7SL380P itself does[4].

Other names
RN7SL380P7SL RNA pseudogene 380
02

Biological functions

Other (no known biological function; typical of processed pseudogenes)
03

Disease associations

Other (no known disease association)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 380, pseudogene (RN7SL380P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 380, pseudogene (RN7SL380P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call